0001493152-20-010820.txt : 20200608
0001493152-20-010820.hdr.sgml : 20200608
20200608212335
ACCESSION NUMBER: 0001493152-20-010820
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200606
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kruger Kurt H
CENTRAL INDEX KEY: 0001375881
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 20950773
MAIL ADDRESS:
STREET 1: 100 FOXBOROUGH BLVD
STREET 2: SUITE 240
CITY: FOXBOROUGH
STATE: MA
ZIP: 02035
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: CARLSBAD
CITY: CALIFORNIA
STATE: CA
ZIP: 92011
BUSINESS PHONE: (760) 918-9165
MAIL ADDRESS:
STREET 1: 2042 CORTE DEL NOGAL
STREET 2: CARLSBAD
CITY: CALIFORNIA
STATE: CA
ZIP: 92011
FORMER COMPANY:
FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090402
4
1
ownership.xml
X0306
4
2020-06-06
0
0001460702
Qualigen Therapeutics, Inc.
QLGN
0001375881
Kruger Kurt H
C/O QUALIGEN THERAPEUTICS, INC.,
2042 CORTE DEL NOGAL
CARLSBAD
CA
92011
1
0
0
0
Stock Option (Right to Buy)
5.13
2020-06-06
4
A
0
50000
0
A
2030-06-06
Common Stock
50000
50000
D
Shares underlying the stock option vest over three years in equal annual installments from the date of grant.
/s/ Hayden Trubitt, Attorney-in-Fact for Kurt H. Kruger
2020-06-08